InflaRx N.V. Cost Of Sales
InflaRx N.V. (IFRX) reported Cost Of Sales of EUR 7.27 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-03-20
- InflaRx N.V. cost of sales for the quarter ending 2025-06-30 was 2.40M EUR, a 589.23% increase year-over-year.
- InflaRx N.V. cost of sales for the quarter ending 2024-06-30 was 348.15K EUR.
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 12 month |
|---|---|---|---|
| 2025-12-31 | 7.27M EUR 20-F · filed 2026-03-20 | ||
| 2025-06-30 | 2.40M EUR 6-K · filed 2025-08-07 | 2.41M EUR 6-K · filed 2025-08-07 | |
| 2024-12-31 | 3.32M EUR 20-F · filed 2026-03-20 | ||
| 2024-06-30 | 348.15K EUR 6-K · filed 2025-08-07 | 568.67K EUR 6-K · filed 2025-08-07 | |
| 2023-12-31 | 532.26K EUR 20-F · filed 2026-03-20 |